Enterome to Move its Research Laboratories to Genopole France's First Biocluster
PARIS September 20 2017 PRNewswire ENTEROME SA a pioneer of innovative therapies for microbiomerelated diseases announced today that the Company is moving its research laboratories to Genopole a...
View ArticleProtagonist Therapeutics Announces Preliminary Phase 1 Study Results with...
NEWARK Calif. Sept. 20 2017 PRNewswire Protagonist Therapeutics Inc. Nasdaq PTGX today announced preliminary results from the Phase 1 study of PTG300 in normal healthy volunteers. PTG300 is an...
View ArticlePSI Opens Office in Taiwan
PSI CRO has announced opening offices in Taiwan listed as Taiwan PSI Health Development Co. Ltd. at Level 37 TAIPEI 101 TOWER No. 7 Sec.5 Xinyi Road Taipei 110 Taiwan. This Smart News Release features...
View ArticleInnovent Biologics Inc Pharmaceuticals Healthcare Deals and Alliances Profile...
SummaryInnovent Biologics Inc Innovent Biologics is a biopharmaceutical company that discovers develops and manufactures monoclonal antibodies. The company's product portfolio comprise monoclonal...
View ArticleInflammatory bowel disease in childhood associated with increased risk of cancer
Children who develop inflammatory bowel disease ulcerative colitis or Crohn's disease run a higher risk of cancer both in childhood and later in life a study from Karolinska Institutet published in the...
View ArticleProvention Bio Announces Licensing Agreements with Janssen for Two...
LEBANON N.J. Sept. 21 2017 PRNewswire Provention Bio Inc. a clinical stage biopharmaceutical company dedicated to sourcing developing and commercializing novel therapeutics aimed at intercepting and...
View ArticleFDA Advisory Committee Recommends Approval of REMICADEÂ for Treatment of...
HORSHAM Pa. July 21 2011 PRNewswire Janssen Biotech Inc. formerly Centocor Ortho Biotech Inc. announced today that the Gastrointestinal Drugs Advisory Committee GIDAC of the U.S. Food and Drug...
View ArticleProvention Bio to Develop Two Janssen GI Immunology Candidates
Johnson & Johnson entities Janssen Pharmaceutica and Janssen Sciences Ireland have outlicensed two gastrointestinal immunology candidates to a startup launched earlier this year under...
View ArticleFirst Xontogeny Fledgling Landos Raises $10M to Develop Autoimmune Disease Drugs
Autoimmune disease therapeutics startup Landos Biopharma raised $10 million in a Series A financing round led by life science investment management firm Perceptive Advisors as the sole investor....
View ArticleFirst Xontogeny Startup Landos Raises $10M to Develop Autoimmune Disease Drugs
Autoimmune disease therapeutics startup Landos Biopharma raised $10 million in a Series A financing round led by life science investment management firm Perceptive Advisors as the sole investor....
View ArticleLandos Biopharma Raises $10 Million in Series A Financing
First company Launched Under Xontogeny Accelerator Model; Chris Garabedian Joins Landos Board to Provide Strategic and Operating Expertise Perceptive Advisors Will Serve as Exclusive Investor Landos...
View ArticleSurgery an Alternative to Infliximab for Some People With Crohns Disease
Reuters Health Information
View ArticleProvention gets two clinical compounds from Janssen
Startup Provention Bio Inc. licensed two clinicalstage GI assets from Janssen Pharmaceutica NVJNJ40346527 for Crohns disease and JNJ42915925CNTO3157 for ulcerative colitis.
View ArticleGlobal Gastrointestinal Partnering 20102017 Deal trends players and...
Global Gastrointestinal Partnering 2010 to 2017 provides the full collection of Gastrointestinal disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends...
View ArticleSoligenix Announces $700000 Subaward Supporting Development Collaboration on...
PRINCETON N.J. Sept. 25 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleMedical Cannabis Companies Leverage Biosynthesis to Boost Drug Development
NEW YORK September 26 2017 PRNewswire Scientists have discovered more than 90 known cannabinoid compounds that may have potential to fight disease and have beneficial health effects. For biotech...
View ArticleNKTR102 Receives Positive Opinion From EMA COMP for Orphan Medicinal Product...
SAN FRANCISCO July 18 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that the European Medicines Agency Committee for Orphan Medicinal Products COMP has issued a positive opinion on...
View ArticleCoronado Biosciences Files to Become a Public Reporting Company
NEW YORK July 18 2011 PRNewswire Coronado Biosciences Inc. the "Company" a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases...
View ArticleAmerican Idol Contestant Casey Abrams Launches Nationwide Contest to Raise...
HORSHAM Pa. July 25 2011 PRNewswire American Idol contestant Casey Abrams is launching a national disease awareness campaign IBD Icons to let people know that living with an inflammatory bowel disease...
View ArticleNektar to Announce Financial Results for the Second Quarter of 2011 on...
SAN FRANCISCO July 27 2011 PRNewswire Nektar Therapeutics Nasdaq NKTR will announce its financial results for the second quarter ended June 30 2011 on Thursday August 4 2011 after the close of...
View Article